BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 18382237)

  • 1. Current decision-making in prostate cancer therapy.
    Cox J; Amling CL
    Curr Opin Urol; 2008 May; 18(3):275-8. PubMed ID: 18382237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence-based patient choice: a prostate cancer decision aid in plain language.
    Holmes-Rovner M; Stableford S; Fagerlin A; Wei JT; Dunn RL; Ohene-Frempong J; Kelly-Blake K; Rovner DR
    BMC Med Inform Decis Mak; 2005 Jun; 5():16. PubMed ID: 15963238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating a decision aid for patients with localized prostate cancer in clinical practice.
    Isebaert S; Van Audenhove C; Haustermans K; Junius S; Joniau S; De Ridder K; Van Poppel H
    Urol Int; 2008; 81(4):383-8. PubMed ID: 19077396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer.
    Davison BJ; Oliffe JL; Pickles T; Mroz L
    Oncol Nurs Forum; 2009 Jan; 36(1):89-96. PubMed ID: 19136342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer treatment decisions: a focus group exploration.
    O'Rourke ME; Germino BB
    Oncol Nurs Forum; 1998; 25(1):97-104. PubMed ID: 9460777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The participation experiences of localized prostate cancer patients in the treatment decision-making process].
    Chien CH; Chuang CK; Liu KL; Liu HE
    Hu Li Za Zhi; 2007 Feb; 54(1):35-42. PubMed ID: 17340546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Information and decision-making preferences of men with prostate cancer.
    Davison BJ; Degner LF; Morgan TR
    Oncol Nurs Forum; 1995 Oct; 22(9):1401-8. PubMed ID: 8539181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Provision of individualized information to men and their partners to facilitate treatment decision making in prostate cancer.
    Davison BJ; Goldenberg SL; Gleave ME; Degner LF
    Oncol Nurs Forum; 2003; 30(1):107-14. PubMed ID: 12515988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Men considering a hypothetical treatment for prostate cancer: a comparison to patients.
    Van Manen L; Feldman-Stewart D; Brundage MD
    Patient Educ Couns; 2006 Apr; 61(1):33-42. PubMed ID: 16257170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Provider and partner interactions in the treatment decision-making process for newly diagnosed localized prostate cancer.
    Zeliadt SB; Penson DF; Moinpour CM; Blough DK; Fedorenko CR; Hall IJ; Smith JL; Ekwueme DU; Thompson IM; Keane TE; Ramsey SD
    BJU Int; 2011 Sep; 108(6):851-6; discussion 856-7. PubMed ID: 21244609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient acceptance of active surveillance as a treatment option for low-risk prostate cancer.
    Davison BJ; Goldenberg SL
    BJU Int; 2011 Dec; 108(11):1787-93. PubMed ID: 21507187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment options for prostate cancer: evaluating the evidence.
    Bhatnagar V; Kaplan RM
    Am Fam Physician; 2005 May; 71(10):1915-22. PubMed ID: 15926407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deciding on radical prostatectomy: a patient's perspective.
    Wegner RE
    Semin Urol Oncol; 2000 Aug; 18(3):192-9. PubMed ID: 10975491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Communicating effectively with the patient and family about treatment options for prostate cancer.
    Kunkel EJ; Myers RE; Lartey PL; Oyesanmi O
    Semin Urol Oncol; 2000 Aug; 18(3):233-40. PubMed ID: 10975496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The patient's dilemma: prostate cancer treatment choices.
    Patel HR; Mirsadraee S; Emberton M
    J Urol; 2003 Mar; 169(3):828-33. PubMed ID: 12576794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient treatment preferences in localized prostate carcinoma: The influence of emotion, misconception, and anecdote.
    Denberg TD; Melhado TV; Steiner JF
    Cancer; 2006 Aug; 107(3):620-30. PubMed ID: 16802287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing treatment decision making and information preferences of prostate cancer patients on active surveillance.
    Davison BJ; Breckon E
    Patient Educ Couns; 2012 Jun; 87(3):369-74. PubMed ID: 22177658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing a generic and individualized information decision support intervention for men newly diagnosed with localized prostate cancer.
    Davison BJ; Goldenberg SL; Wiens KP; Gleave ME
    Cancer Nurs; 2007; 30(5):E7-15. PubMed ID: 17876177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparatory education for informed decision-making in prostate cancer early detection and treatment.
    Myers RE; Kunkel EJ
    Semin Urol Oncol; 2000 Aug; 18(3):172-7. PubMed ID: 10975487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comorbidity and primary treatment for localized prostate cancer: data from CaPSURE.
    Marr PL; Elkin EP; Arredondo SA; Broering JM; DuChane J; Carroll PR
    J Urol; 2006 Apr; 175(4):1326-31. PubMed ID: 16515991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.